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Abstract
Background: We have developed magnetite cationic liposomes (MCLs) and applied them to local
hyperthermia as a mediator. MCLs have a positive charge and generate heat under an alternating
magnetic field (AMF) by hysteresis loss. In this study, the effect of hyperthermia using MCLs was
examined in an in vivo study of hamster osteosarcoma.
Method: MCLs were injected into the osteosarcoma and then subjected to an AMF.
Results: The tumor was heated at over 42°C, but other normal tissues were not heated as much.
Complete regression was observed in 100% of the treated group hamsters, whereas no regression
was observed in the control group hamsters. At day 12, the average tumor volume of the treated
hamsters was about 1/1000 of that of the control hamsters. In the treated hamsters, no regrowth
of osteosarcomas was observed over a period of 3 months after the complete regression.
Conclusion: These results suggest that this treatment is effective for osteosarcoma.
Background
Magnetite nanoparticles have been used in biological and
medical applications, such as the separation of biological
materials using magnetically labeled beads [1], drug deliv-
ery and medicine [2], or cell sorting, based on the fact that
high magnetic flux density attracts magnetically labeled
cells [3-5]. We previously developed "magnetite cationic
liposomes" (MCLs), which are cationic liposomes con-
taining 10-nm magnetite nanoparticles, in order to
improve the accumulation of magnetite nanoparticles in
target cells using the electrostatic interaction between
MCLs and the cell membrane [6]. Currently, we have
developed a tissue engineering technique using MCLs [7-
9]. Mesenchymal stem cells (MSCs), which can differenti-
ate into multiple mesodermal tissues, can be isolated
from bone marrow in a small number. Magnetically
labeled MSCs were easily prepared, because our MCLs
exhibited no toxicity against the MSCs in proliferation
and differentiation, and then the MSCs were enriched into
the localized area that the magnetic force can reach. Cell
growth was promoted and a five-fold increase in cell
number was obtained at 7 days after cell seeding [7]. To
establish 3D in vivo-like tissues consisting of various types
of cells, we applied MCLs to the co-culture system of rat
hepatocytes and human aortic endothelial cells (HAECs).
Magnetically labeled HAECs accumulated onto
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hepatocyte monolayers by magnetic force to form a heter-
otypic, layered construct with tight and close contact.
Albumin secretion by hepatocytes was about three times
higher than that of the control co-culture system without
magnetic force [8]. MCLs were also applied to construct
multilayered keratinocyte sheets. On a 24-well ultra-low-
attachment plate, a 5-layered keratinocyte sheet was first
produced and a 10-layered epidermal sheet was formed in
a high-calcium medium. The sheet formed ordinarily was
detached from the bottom of the plate when the magnet
was removed, and transplantation to the patient was eas-
ily performed [9]. We have termed this culture methodol-
ogy as "magnetic force-based tissue engineering (Mag-
TE)". We have also used MCLs as a heating mediator for
cancer hyperthermia, because magnetite nanoparticles
generate heat under an alternating magnetic field (AMF)
[10-13].
Hyperthermia is one of the promising approaches in can-
cer therapy, and various methods have been employed in
hyperthermia [14,15]. The most commonly used heating
method in clinical settings is capacitive heating using a
radiofrequency (RF) electric field [16]. However, heating
tumors specifically by capacitive heating using an RF elec-
tric field is difficult, because the heating characteristics are
influenced by various factors such as tumor size, position
of electrodes, and adhesion of electrodes at uneven sites.
From a clinical point of view, a simple heat mediator is
more desirable not only for superficially located tumors
but also for deep-seated tumors. Some researchers have
proposed inductive heating methods, using submicron
magnetic particles, for hyperthermia [17,18]. We have
also developed MCLs for intracellular hyperthermia
[6,10,11], which showed a ten-fold higher affinity for the
tumor cells than neutrally charged magnetoliposomes
[10]. Based on this feature, MCLs can be highly superior
heating mediators. We previously demonstrated the effi-
cacy of MCL-mediated hyperthermia in animals with sev-
eral types of tumors, including B16 mouse melanoma
[19,20], T-9 rat glioma [11,21], renal cell carcinoma [22],
and VX-7 squamous cell carcinoma in rabbit tongue [23].
We also reported complete regression of mouse mammary
carcinoma, larger than 15 mm in size, by frequent
repeated hyperthermia [24]. Although MCL-mediated
hyperthermia was found to be very effective for inducing
complete regression of tumors, no studies have investi-
gated the biodistribution of MCLs after local injection.
Osteosarcoma is a primary malignant tumor of the bone
that mostly occurs in growing children and young adults
[25]. Effective systemic adjuvant chemotherapy on the
primary tumor and improvements in surgical resection
techniques have improved the survival rate. However,
these have not proved to be sufficiently effective, and a
more effective protocol for the prevention and treatment
of osteosarcoma is needed.
Therefore, in the present paper, our hyperthermia system
was applied to hamster osteosarcoma and its hyperther-
mic effect was investigated.
Materials and methods
Animals and osteosarcoma models
Three-week-old Syrian female hamsters were purchased
from Japan SLC, Inc., Shizuoka, Japan, and used for the
animal study.
Experimentally transplantable osteosarcoma Os515,
induced by the BK virus, was used [25]. Since it was very
difficult to culture the cells in a liquid medium using a
dish, the osteosarcoma tissue of Os515 was maintained
by the transplanting it in the Syrian hamsters.
Preparation of tumor-bearing hamsters
Minced osteosarcoma fragments (100 µ l )  w e r e  t r a n s -
planted into the subcutaneous layer of the back of Syrian
female hamsters, which were anesthetized by an intraperi-
toneal injection of sodium pentobarbital (50 mg/kg body
weight). Tumor size was measured every 3 days. The vol-
ume and the ratio of tumor volume were determined by
the following formulas [10]:
Sarcoma volume = 0.5 × (length × width2)
Ratio of tumor volume = (sarcoma volume on each day) /
(sarcoma volume before hyperthermia),
where the unit of length and width is expressed in
centimeters.
Animal experiments were performed according to the
principles laid down in the "Guide for the Care and Use
of Laboratory Animals" prepared under the directions of
the Office of the Prime Minister of Japan.
Preparation of MCLs
Magnetic particles were kindly donated by Toda Kogyo
Co. (Hiroshima, Japan; average particle size of magnetite:
10 nm). MCLs were prepared using the previously
described sonication method, with slight modification
[6]. Briefly, 1 ml of colloidal magnetite (net 20 mg mag-
netite) was coated with a lipid membrane that consisted
of  N-(α-trimethylammonioacetyl) didodecyl-D-gluta-
mate chloride (Sogo Pharmaceutical Co., Tokyo), dilau-
roylphosphatidylcholine, and
dioleoylphosphatidylethanolamine (Sigma Chemical
Co., St. Louis, MO, USA) in a molar ratio of 1:2:2. Magnet-
ite concentration was measured using the potassium thio-
cyanate method [22].BioMagnetic Research and Technology 2004, 2 http://www.biomagres.com/content/2/1/3
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Hyperthermia treatment
After the tumors had grown to about 10 mm in diameter,
a syringe (25 G needle) containing MCLs was longitudi-
nally inserted into each osteosarcoma nodule, subcutane-
ously from the nodule edge. MCLs (0.4 ml, net magnetite
weight: 3 mg) were injected using an infusion pump
(SP100i; World Precision Instruments Inc., Sarasota, FL,
USA) for 30 min. The hamsters were then separated into
control (n = 4) and treatment (n = 4) groups. The hamsters
in group I (control) were not subjected to AMF. In group
II (treatment group), 24 h after the injection, the hamsters
were subjected to the first hyperthermia treatment after
being anesthetized by an intraperitoneal injection of
sodium pentobarbital (50 mg/kg body weight). A mag-
netic field was created using a horizontal coil (inner diam-
eter, 7 cm; length, 7 cm) with a transistor inverter (LTG-
100-05; Dai-ichi High Frequency Co., Tokyo). The mag-
netic field frequency was 118 kHz. The hamster was
placed inside the coil such that the nodule was positioned
at the center of the coil. Temperatures at the surface of the
tumor tissue and in the rectum during AMF were meas-
ured by an optical fiber probe (FX-9020; Anritsu Meter
Co., Tokyo). The treatment was carried out for 30 min,
three times at 24 h intervals.
Results
Heat generation by MCLs in an alternating magnetic field
Figure 1 shows the temperature increase at the outside
skin covering the osteosarcoma and in the rectum. The
temperature of the osteosarcoma was rapidly elevated by
magnetic heating and reached over 42°C after 10 min; it
was maintained at the same temperature by controlling
the magnetic field intensity. In contrast, the temperature
in the rectum remained between 37–39°C. These results
indicate that using MCLs for hyperthermia makes it feasi-
ble to heat only tumor, and not damage healthy tissues.
Monitoring tumor growth after hyperthermia
Figure 2 shows the time courses of osteosarcoma growth
in the control and treatment groups. In the control group,
the growth ratio of osteosarcoma in each hamster steadily
increased with no evidence of regression. In contrast,
complete regression of osteosarcoma was observed in
100% of the hamsters in the treatment group. In two
cases, the osteosarcoma volume increased until day 4 or
10, after which it began to decrease and finally disap-
peared. Figure 3 shows photographs of typical hamsters
from the treatment (A) and control (B) groups, at day 20
after the MCL injection. Osteosarcomas in the treatment
group hamsters clearly disappeared and the skin was also
quite normal.
In the treatment group, all osteosarcomas disappeared by
day 15 and no regrowth of osteosarcomas was observed
over a period of 3 months. As shown in Table 1, tumor
volume was compared at day 12 of the MCL injection,
because two control hamsters died on day 12. At day 12 of
the MCL injection, 75% of the osteosarcomas disap-
peared, and the average tumor volume of the treated ham-
sters was about 1/1000 that of the control hamsters.
Although there were only four hamsters in each group, it
has been proven that our hyperthermia was a significantly
effective treatment for osteosarcoma.
Discussion
The treatment of osteosarcoma usually involves the
administration of anticancer drugs or surgery or a
combination of both. In such cases, several side effects of
drugs and the mutilation of arms or legs cause patients
additional pain. Hyperthermia is a promising approach
for the treatment of osteosarcoma. Although radiofre-
quency capacitive heating has performed well as a heating
method, electric waves cannot be focused on the tumor
tissue and may affect, and thereby damage, normal bone
tissue. Therefore, although several researchers have pro-
posed simulation of heating to prevent such side effects
[26,27], it is not a fundamental solution. Inductive heat-
ing has a great advantage of hyperthermia for osteosar-
coma in bone because the magnetic field used in this
therapy does not cause bone decay. Takegami et al. have
proposed a ferromagnetic bone cement as a thermoseed
to generate heat by hysteresis loss under an AMF [28]. The
heat-generating ability was investigated using rabbit and
human cadaver tibiae in which this thermoseed was
implanted. By applying a magnetic field with a maximum
Temperature increase at outside of the tumor center (closed  circles) and in the rectum (open circles) Figure 1
Temperature increase at outside of the tumor center (closed 
circles) and in the rectum (open circles). The temperature at 
the outside of the tumor center was maintained at 42°C. 
Data points and bars represent the mean and SD of the 3 
independent experiments, respectively.
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of 300 Oe and 100 kHz, it was found that the temperature
increase of the thermoseed implanted bone was beyond
50°C. However, implanted magnetic cement remains in
patient bone. Therefore, it should be carefully investigated
whether long-term deposits of magnetite affects patient
health, that is, acute and/or chronic toxicity by excess
absorption of Fe ions, e.g., hemochromatosis [29]. In our
previous study, the magnetic particles administered were
completely cleared from the body within 10 days in the
case of mice [30].
We have performed hyperthermia using magnetic parti-
cles against brain tumor, tongue cancer, kidney cancer,
and a malignant melanoma. In the present study, the
effect of hyperthermia was investigated against a hamster
osteosarcoma. Although it is an elementary investigation
using subcutaneous tumor, the anti-tumor effect against
the osteosarcoma was confirmed. Moreover, it should be
noted that the treatment temperature was only 42°C. In
the case of melanoma-bearing mice, a more efficient treat-
ment effect was observed when the treatment at 46°C was
carried out and complete regression was obtained [19]. In
addition, mouse mammary carcinoma, larger than 15 mm
in size, was also completely regressed. Furthermore, all
large tumors disappeared within 70 days when frequent
repeated treatment involving MCL injection was carried
out, whereas all control mice died within 52 days [24].
Therefore, sufficient treatment effect can be also expected
for large osteosarcomas and/or malignant invasive
orteosarcoma.
From the present results, it can also be stated the essential
advantage of hyperthermia, i.e., the fact that the hyper-
thermic effect is independent of the type of cancer cell,
Time courses of tumor growth after the MCL injection for control (A) and treatment (B) groups Figure 2
Time courses of tumor growth after the MCL injection for control (A) and treatment (B) groups. Tumor regrowth was not 
observed within 3 months in hamsters showing complete regression. ×: The day the hamsters died.
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was reconfirmed. We succeeded in demonstrating the
hyperthermic effect using a hamster model in addition to
mouse, rat, and rabbit. The present results prove that
hyperthermia is a reliable and effective cancer therapy
across species.
In future work, it is necessary to study the medical effects
against osteosarcomas that originate in bone cells, such as
in the femur. In this case, it will be necessary to monitor
the distribution of magnetic particles in the tumor and/or
bone marrow. When a dense magnetic particle solution is
flowed to the bone marrow, the toxic effect to the systemic
Typical photographs of hamsters on day 20 after the MCL injection Figure 3
Typical photographs of hamsters on day 20 after the MCL injection. These photographs show one hamster of the treatment 
(A) group and one of the control group (B).
Table 1: Hyperthermic effect on subcutaneous tumor 12 days after the magnetite cationic liposomes injection
Group Number of rats tested Average tumor volumea (mm3) Relative tumor volumeb Complete regressionc (%)
Control 4 3006 1 0
Treatment 4 27 0.009 75 (100% at 15 days)
a: Tumor volume = 0.5 × (length × width2) b: Relative tumor volume = (average tumor volume in treatment group) / (average tumor volume in 
control group) c: hyperthermic effect in two groups was compared at 12 days after MCL injection since two control hamster died at 12 days. At 15 
days, all treated hamsters cured completely.
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immune system should be carefully investigated. If
particles are localized into the tumor tissues in the bone,
it will be easy to heat the tumor because heat quenching
by the blood flow is ignored and a high hyperthermic
effect will be expected.
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